Watson for Genomics: Moving Personalized Medicine Forward

Trends in Cancer

Volumn 2, Issue 8, 2016, Pages 392-395

  Rhrissorrakrai, Kahn ^a   Koyama, Takahiko ^a   Parida, Laxmi ^a  

^a IBM RESEARCH   (United States)

Author keywords

cognitive computing; genomics; personalized medicine; theranostics

Indexed keywords

BIOLOGICAL MARKER;

ANALYTICAL EQUIPMENT; CLINICAL OUTCOME; CLOUD COMPUTING; DNA MICROARRAY; GENE MUTATION; GENOME ANALYSIS; GENOMICS; HUMAN; MEDICAL DECISION MAKING; METASTASIS; NEOPLASM; PATIENT CARE; PERSONALIZED MEDICINE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SHORT SURVEY; TUMOR GENE; BIOLOGY;

COMPUTATIONAL BIOLOGY; GENOMICS; HUMANS; PRECISION MEDICINE;

EID: 84979609922     PISSN: 24058033     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trecan.2016.06.008     Document Type: Short Survey

References (3)

1. 1 Garraway, L.A., Genomics-driven oncology: framework for an emerging paradigm. J. Clin. Oncol. 31 (2013), 1806–1814.
2. 2 Tufts Center for the Study of Drug Development. Lack of clinically useful diagnostics hinder growth in the personalized medicines., 2011, Impact Report 13 July/August.
3. 3 Cho, S.-H., et al. Personalized medicine in breast cancer: a systematic review. J. Breast Cancer, 2012, 265–272.